Amicus Therapeutics Inc (FOLD) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.33
• Market Cap: $4.50B
• EPS: $-0.04
• 52-Week High: $14.38
• 52-Week Low: $5.51

Market Sentiment

Amicus Therapeutics Inc currently has a Neutral sentiment score of 0.06.

About Amicus Therapeutics Inc

Amicus Therapeutics, Inc. (FOLD) is a pioneering biopharmaceutical firm based in Philadelphia, Pennsylvania, committed to developing innovative therapies for rare metabolic disorders. Utilizing its proprietary enzyme replacement therapy platform, Amicus focuses on creating personalized medicine solutions that cater to previously neglected patient populations. The company boasts a promising pipeline of advanced therapeutics targeting lysosomal storage disorders, solidifying its reputation as a...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Amicus Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FOLD pay dividends?

Amicus Therapeutics Inc (FOLD) does not currently pay a regular dividend.

What is FOLD's market cap?

Amicus Therapeutics Inc (FOLD) has a market capitalization of $4.50B with a current stock price of $14.33.